Min Seong Jang
Overview
Explore the profile of Min Seong Jang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee P, Kim J, Oh H, Kim C, Jeong A, Lee M, et al.
Antiviral Res
. 2024 Aug;
231:105991.
PMID: 39181216
Most coronavirus vaccines focus on the spike (S) antigen, but the frequent mutations in S raise concerns about the vaccine efficacy against new variants. Although additional antigens with conserved sequences...
2.
Park H, Jang M, Choi J, Kim W, Kim Y, Kim N, et al.
Vaccine
. 2023 Oct;
41(46):6842-6851.
PMID: 37821316
The worldwide health, economic, and societal consequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have been devastating. The primary strategy to prevent new infectious diseases is to...
3.
Park S, Jang M, Lim K, Seo J, Im W, Han K, et al.
Arch Toxicol
. 2023 Jul;
97(9):2429-2440.
PMID: 37491472
The coronavirus disease 2019 pandemic has resulted in the introduction of several naïve methods of vaccine development, which have been used to prepare novel viral vectors and mRNA-based vaccines. However,...
4.
Ko M, Lee J, Shin Y, Jeon S, Myung S, Cho J, et al.
J Med Virol
. 2023 Jun;
95(6):e28863.
PMID: 37310127
The ongoing COVID-19 has not only caused millions of deaths worldwide, but it has also led to economic recession and the collapse of public health systems. The vaccines and antivirals...
5.
Oh S, Jang M, Jung K, Han J, Lee H, Gil A, et al.
Arch Toxicol
. 2023 Jan;
97(4):1177-1189.
PMID: 36683063
pGO-1002, a non-viral DNA vaccine that expresses both spike and ORF3a antigens of SARS-CoV-2, is undergoing phase 1 and phase 2a clinical trials in Korea and the US. A preclinical...
6.
Koo B, Seo J, Jang M
Animals (Basel)
. 2022 Oct;
12(20).
PMID: 36290261
Biomass and abundance are fundamental parameters in ecology, conservation biology, and environmental impact assessment. Distinguishing features, such as burrow openings and feeding pellets, made by different intertidal macroinvertebrate species on...
7.
Shin Y, Lee J, Jeon S, Cho J, Myung S, Jang M, et al.
Pharmaceuticals (Basel)
. 2022 Jul;
15(7).
PMID: 35890130
We previously reported the potent antiviral effect of the 2-aminoquinazolin-4-(3)-one , which shows significant activity (IC = 0.23 μM) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with no cytotoxicity....
8.
Lee J, Shin Y, Jeon S, Lee S, Cho J, Myung S, et al.
Bull Korean Chem Soc
. 2022 Apr;
43(3):412-416.
PMID: 35440837
Despite the continuing global crisis caused by coronavirus disease 2019 (COVID-19), there is still no effective treatment. Therefore, we designed and synthesized a novel series of 2-benzylaminoquinazolin-4(3)-one derivatives and demonstrated...
9.
Jin Y, Jeon S, Lee J, Kim S, Jang M, Park C, et al.
Pharmaceutics
. 2022 Feb;
14(2).
PMID: 35214108
The rhizome of Nakai. (Dryopteridaceae) has been used in traditional medicine in East Asia and has recently been reported to have anticancer, anti-inflammation, and antibacterial activity as well as antiviral...
10.
Jin Y, Jeon S, Lee J, Kim S, Jang M, Park C, et al.
Pharmaceutics
. 2021 Nov;
13(11).
PMID: 34834252
Cardiotonic steroids are steroid-like natural compounds known to inhibit Na/K-ATPase pumps. To develop a broad-spectrum antiviral drug against the emerging coronavirus infection, this study assessed the antiviral properties of these...